When should a bedside transthoracic echocardiogram be ordered for a patient with bilateral pulmonary emboli?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

When to Order Bedside Transthoracic Echocardiography for Bilateral Pulmonary Emboli

Order a bedside transthoracic echocardiogram immediately if the patient with bilateral PE presents with shock, hypotension, or hemodynamic instability, especially when CT is not immediately available or the patient is too unstable to transport. 1

Risk-Based Approach to Echo Ordering

The decision to order TTE depends critically on the patient's hemodynamic status and clinical presentation:

Immediate TTE is Recommended:

  • High-risk PE with shock or hypotension - TTE should be performed urgently when the patient is hemodynamically unstable and CT pulmonary angiography is not immediately available 1. The absence of RV pressure overload or dysfunction on echo virtually excludes massive PE as the cause of instability 1.

  • Cardiac arrest or peri-arrest situations - Immediate echocardiography is mandatory to identify massive PE, which can be recognized without interfering with resuscitation quality 2.

  • Guiding therapeutic decisions in intermediate-risk PE - When considering escalation to reperfusion therapy or advanced interventions, TTE helps stratify risk by identifying RV dysfunction 1.

TTE is Reasonable:

  • Intermediate-risk stratification - In normotensive patients, TTE can differentiate intermediate-risk (RV dysfunction present) from low-risk PE (no RV dysfunction) 1. Tricuspid annular plane systolic excursion below 15 mm carries adverse prognostic significance 2.

  • Searching for right heart thrombus - TTE may identify clot-in-transit in the right atrium or ventricle, which escalates risk stratification and alters management 3.

TTE is NOT Recommended:

  • Stable, normotensive patients with confirmed PE - TTE is not mandatory in the emergency setting for hemodynamically stable patients 2, 1. In fact, recent quality improvement data shows that 79% of TTEs ordered for normotensive PE patients were inappropriate 4.

Key Echocardiographic Findings and Their Limitations

Important caveat: TTE has consistently high specificity (83%) but low sensitivity (53%) for PE diagnosis 5. This makes it useful as a "rule-in" test at the bedside but inadequate to exclude PE.

Direct Signs (Rare):

  • Visualization of thrombus in main or proximal pulmonary arteries (associated with increased mortality) 2
  • Clot-in-transit in right atrium/ventricle 3

Indirect Signs of RV Strain:

  • RV dilation and dysfunction
  • McConnell's sign (RV apex hyperkinesia with lateral wall hypokinesia) 6
  • Abnormal septal motion with leftward shift
  • Tricuspid regurgitation allowing pressure estimation
  • Critical distinction: In acute PE, pulmonary artery systolic pressure typically does not exceed 60 mmHg (tricuspid regurgitant jet velocity 2.5-3.5 m/s). Higher pressures suggest chronic or recurrent PE 1.

Algorithmic Decision Framework

For bilateral PE patients:

  1. Is the patient hypotensive or in shock?

    • YES → Order immediate bedside TTE 1
    • NO → Proceed to step 2
  2. Is the patient stable and normotensive?

    • YES → TTE not routinely indicated in emergency setting 2, 1
    • Consider non-urgent TTE for complications assessment
    • NO → Proceed to step 3
  3. Are you considering escalation to reperfusion therapy or advanced interventions?

    • YES → Order TTE to assess RV function and guide therapeutic decisions 1
    • NO → TTE likely not indicated
  4. Can the patient safely undergo CT pulmonary angiography?

    • YES → CT is preferred for diagnosis; TTE reserved for risk stratification
    • NO → TTE becomes more valuable for bedside assessment 7

Common Pitfalls to Avoid

  • Don't order routine TTEs on all normotensive PE patients - This represents inappropriate utilization and adds unnecessary cost without changing management 4.

  • Don't rely on TTE alone to exclude PE - The negative predictive value is only 40-50% 2. If clinical suspicion remains after negative TTE, proceed with definitive imaging.

  • Don't delay thrombolysis waiting for cardiology interpretation - In massive PE with hemodynamic collapse, rescue reperfusion may be indicated based on emergency physician-performed TTE alone 7.

  • Don't misinterpret high pulmonary pressures - Pressures >60 mmHg suggest chronic disease rather than acute PE 1.

Related Questions

What admission orders should be placed for a patient with pulmonary embolism?
What examinations should be ordered to rule out pulmonary embolism in the emergency department?
What are the 2026 guidelines for the management of pulmonary embolism?
In a 38-year-old woman with persistent dyspnea four months after an acute pulmonary embolism treated with three months of anticoagulation, which test should be ordered next: a 6‑minute walk test, CT pulmonary angiography, ventilation‑perfusion (V/Q) lung scan, or pulmonary angiography?
Can a patient develop a pulmonary embolism despite being on therapeutic anticoagulation?
What is the recommended medication regimen for treating depression in a pregnant woman?
What are the commercial (brand) names for escitalopram 5 mg tablets?
When should fever be treated, including temperature thresholds and patient-specific factors such as age, health status, and associated symptoms?
What is the likely diagnosis for a 1‑ to 4‑year‑old child with acute elbow pain and limited use after a forearm pull?
In a 4‑month‑old infant with non‑traumatic petechiae on the medial aspects of both femurs and laboratory findings of normal platelet count, normal prothrombin time (PT), normal activated partial thromboplastin time (aPTT), normal von Willebrand factor (vWF) antigen, reduced von Willebrand factor activity (~40 %), and normal factor VIII, what is the appropriate next step in management?
How should I explain hepatitis C virus infection to a patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.